Cargando…
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
Anterior gradient 2 (AGR2), a protein disulfide isomerase, shows two subcellular localizations: intracellular (iAGR2) and extracellular (eAGR2). In healthy cells that express AGR2, the predominant form is iAGR2, which resides in the endoplasmic reticulum. In contrast, cancer cells secrete and expres...
Autores principales: | Liu, Alvin Y., Kanan, Adelle D., Radon, Tomasz P., Shah, Siama, Weeks, Mark E., Foster, Julie M., Sosabowski, Jane K., Dumartin, Laurent, Crnogorac-Jurcevic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611513/ https://www.ncbi.nlm.nih.gov/pubmed/31303962 http://dx.doi.org/10.18632/oncotarget.26945 |
Ejemplares similares
-
ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation
por: Dumartin, L, et al.
Publicado: (2017) -
Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
por: Alrawashdeh, Wasfi, et al.
Publicado: (2019) -
Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017) -
Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020) -
Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets
por: Chelala, Claude, et al.
Publicado: (2007)